Neurotrophins and neurodegenerative diseases: Receptors stuck in traffic?

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 4, 2003, Pages 340-350

  Kruttgen, Alex ^a   Saxena, Smita ^a   Evangelopoulos, Maria Eleptheria ^a   Weis, Joachim ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Alzheimer disease; BDNF; Huntington disease; Neurotrophins; NGF; Parkinson disease; Trafficking

Indexed keywords

NEUROTROPHIC FACTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR;

AMYOTROPHIC LATERAL SCLEROSIS; CELL NUCLEUS; CELL SURVIVAL; CLINICAL TRIAL; DEGENERATIVE DISEASE; HUMAN; MUTATION; NERVE CELL; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NERVE FIBER; NERVE FIBER GROWTH; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; SYNAPSE;

EID: 0037384814     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.4.340     Document Type: Review

References (97)

1. Huang EJ, Reichardt LF. Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 2001;24:677-36
2. Roux PP, Barker PA. Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 2002;67:203-33
3. Schecterson LC, Bothwell M. Novel roles for neurotrophins are suggested by BDNF and NT-3 mRNA expression in developing neurons. Neuron 1992;9:449-63
4. Segal RA, Greenberg ME. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 1996;19:463-89
5. Kruttgen A, Saxena S, Evangelopoulos ME, Weis J. Neurotrophins and retrograde signaling: A long distance relationship. Neuroembryology 2002;1:128-40
6. Kafitz KW, Rose CR, Thoenen H, Konnerth A. Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 1999;401: 918-21
7. Finkbeiner S, Tavazoie SF, Maloratsky A, et al. CREB: A major mediator of neuronal neurotrophin responses. Neuron 1997;19: 1031-47
8. Terwel D, Dewachter L, Van Leuven F. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. Neuromolecular Med 2002;2:151-65
9. Julien JP. A role for neurofilaments in the pathogenesis of amyotrophic lateral sclerosis. Biochem Cell Biol 1995;73:593-97
10. Appel SH. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann Neurol 1981;10:499-505
11. Varon S, Manthorpe M, Williams LR. Neuronotrophic and neurite-promoting factors and their clinical potentials. Dev Neurosci 1983; 6:73-100
12. Burek MJ, Oppenheim RW. Programmed cell death in the developing nervous system. Brain Pathol 1996;6:427-46
13. Bibel M, Barde YA. Neurotrophins: Key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000;14: 2919-37
14. Snider WD. Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell 1994;77: 627-38
15. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000;407:802-9
16. Xu B, Zang K, Ruff NL, et al. Cortical degeneration in the absence of neurotrophin signaling: Dendritic retraction and neuronal loss after removal of the receptor TrkB. Neuron 2000;26:233-45
17. Ruit KG, Osborne PA, Schmidt RE, Johnson EM, Jr, Snider WD. Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J Neurosci 1990;10:2412-19
18. Ventriglia M, Bocchio Chiavetto L, Benussi L, et al. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry 2002;7:136-37
19. Kunugi H, Ueki A, Otsuka M, et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 2001;6:83-86
20. Momose Y, Murata M, Kobayashi K, et al. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann Neurol 2002;51:133-36
21. Giess R, Holtmann B, Braga M, et al. Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: Potential impact of CNTF as a candidate modifier gene. Am J Hum Genet 2002; 70:1277-86
22. Siegel GJ, Chauhan NB. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Brain Res Rev 2000;33: 199-227
23. Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 2001;63:71-124
24. Nagatsu T, Mogi M, Ichinose H, Togari A. Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm Suppl 2000;60:277-90
25. Mufson EJ, Kroin JS, Sendera TJ, Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases. Prog Neurobiol 1999;57:451-84
26. Nishio T, Furukawa S, Akiguchi I, Sunohara N. Medial nigral dopamine neurons have rich neurotrophin support in humans. Neuroreport 1998;9:2847-51
27. Nishio T, Sunohara N, Furukawa S. Neutrophin switching in spinal motoneurons of amyotrophic lateral sclerosis. Neuroreport 1998;9: 1661-65
28. Fahnestock M, Michalski B, Xu B, Coughlin MD. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 2001;18:210-20
29. Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: Decreased levels in Alzheimer's disease. Brain Res Mol Brain Res 2000;76: 347-54
30. Ferrer I, Marin C, Rey MJ, et al. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 1999;58:729-39
31. Allen SJ, Wilcock GK, Dawbarn D. Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease. Biochem Biophys Res Commun 1999;264:648-51
32. Durany N, Michel T, Kurt J, et al. Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains. Int J Dev Neurosci 2000;18:807-13
33. Salehi A, Ocampo M, Verhaagen J, Swaab DF. P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease. Exp Neurol 2000;161:245-58
34. Aguado F, Ballabriga J, Pozas E, Ferrer I. TrkA immunoreactivity in reactive astrocytes in human neurodegenerative diseases and colchicine-treated rats. Acta Neuropathol (Berl) 1998;96:495-501
35. Soontornniyomkij V, Wang G, Pittman CA, et al. Absence of brain-derived neurotrophic factor and trkB receptor immunoreactivity in glia of Alzheimer's disease. Acta Neuropathol (Berl) 1999;98: 345-48
36. Altar CA, DiStefano PS. Neurotrophin trafficking by anterograde transport. Trends Neurosci 1998;21:433-37
37. Duberley RM, Johnson IP, Anand P, Leigh PN, Cairns NJ. Neurotrophin-3-like immunoreactivity and Trk C expression in human spinal motoneurones in amyotrophic lateral sclerosis. J Neurol Sci 1997;148:33-40
38. Mutoh T, Sobue G, Hamano T, et al. Decreased phosphorylation levels of TrkB neurotrophin receptor in the spinal cords from patients with amyotrophic lateral sclerosis. Neurochem Res 2000;25: 239-45
39. Kust BM, Copray JC, Brouwer N, Troost D, Boddeke HW. Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp Neurol 2002;177:419-27
40. Snider WD, Lichtman JW. Are neurotrophins synaptotrophins? Mol Cell Neurosci 1996;7:433-42
41. Gruenberg J. The endocytic pathway: A mosaic of domains. Nat Rev Mol Cell Biol 2001;2:721-30
42. Stahl PD, Barbieri MA. Multivesicular bodies and multivesicular endosomes: The "ins and outs" of endosomal traffic. Sci STKE 2002;2002:PE32
43. Parton RG, Simons K, Dotti CG. Axonal and dendritic endocytic pathways in cultured neurons. J Cell Biol 1992;119:123-37
44. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991;14:453-501
45. Beattie EC, Zhou J, Grimes ML, et al. A signaling endosome hypothesis to explain NGF actions: Potential implications for neurodegeneration. Cold Spring Harb Symp Quant Biol 1996;61: 389-406
46. Schlessinger J. All signaling is local? Mol Cell 2002;10:218-19
47. MacInnis BL, Campenot RB. Retrograde support of neuronal survival without retrograde transport of nerve growth factor. Science 2002;295:1536-39
48. Schnapp BJ. Retroactive motors. Neuron 1997;18:523-26
49. Muresan V. One axon, many kinesins: What's the logic? J Neurocytol 2000;29:799-818
50. Bhattacharyya A, Watson FL, Pomeroy SL, et al. High-resolution imaging demonstrates dynein-based vesicular transport of activated Trk receptors. J Neurobiol 2002;51:302-12
51. Grimes ML, Beattie E, Mobley WC. A signaling organelle containing the nerve growth factor-activated receptor tyrosine kinase, TrkA. Proc Natl Acad Sci U S A 1997;94:9909-14
52. Grimes ML, Zhou J, Beattie EC, et al. Endocytosis of activated TrkA: Evidence that nerve growth factor induces formation of signaling endosomes. J Neurosci 1996;16:7950-64
53. Howe CL, Valletta JS, Rusnak AS, Mobley WC. NGF signaling from clathrin-coated vesicles: Evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway. Neuron 2001;32: 801-14
54. Yano H, Lee FS, Kong H, et al. Association of Trk neurotrophin receptors with components of the cytoplasmic dynein motor. J Neurosci 2001;21:RC125
55. Watson FL, Heerssen HM, Moheban DB, et al. Rapid nuclear responses to target-derived neurotrophins require retrograde transport of ligand-receptor complex. J Neurosci 1999;19:7889-7900
56. Tsui-Pierchala BA, Ginty DD. Characterization of an NGF-P-TrkA retrograde-signaling complex and age-dependent regulation of TrkA phosphorylation in sympathetic neurons. J Neurosci 1999;19: 8207-18
57. Neet KE, Campenot RB. Receptor binding, internalization, and retrograde transport of neurotrophic factors. Cell Mol Life Sci 2001; 58:1021-35
58. Verveer PJ, Wouters FS, Reynolds AR, Bastiaens PI. Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane. Science 2000;290:1567-1570
59. Ni CY, Murphy MP, Golde TE, Carpenter G. gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 2001;294:2179-81
60. Tsui-Pierchala BA, Milbrandt J, Johnson EM, Jr. NGF utilizes c-Ret via a novel GFL-independent, inter-RTK signaling mechanism to maintain the trophic status of mature sympathetic neurons. Neuron 2002;33:261-73
61. Zhang Y, Moheban DB, Conway BR, Bhattacharyya A, Segal RA. Cell surface Trk receptors mediate NGF-induced survival while internalized receptors regulate NGF-induced differentiation. J Neurosci 2000;20:5671-78
62. Zhang M, Dwyer NK, Love DC, et al. Cessation of rapid late endosomal tubulovesicular trafficking in Niemann-Pick type C1 disease. Proc Natl Acad Sci U S A 2001;98:4466-71
63. Henderson LP, Lin L, Prasad A, et al. Embryonic striatal neurons from niemann-pick type C mice exhibit defects in cholesterol metabolism and neurotrophin responsiveness. J Biol Chem 2000;275: 20179-87
64. Velier J, Kim M, Schwarz C, et al. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp Neurol 1998;152:34-40
65. Song C, Perides G, Liu YF. Expression of full-length polyglutamine-expanded Huntingtin disrupts growth factor receptor signaling in rat pheochromocytoma (PC12) cells. J Biol Chem 2002;277: 6703-7
66. Li Y, Chin LS, Levey AI, Li L. Huntingtin-associated protein 1 interacts with hepatocyte growth factor-regulated tyrosine kinase substrate and functions in endosomal trafficking. J Biol Chem 2002; 277:28212-21
67. Singaraja RR, Hadano S, Metzler M, et al. HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis. Hum Mol Genet 2002;11:2815-28
68. Raiborg C, Bache KG, Mehlum A, Stenmark H. Function of Hrs in endocytic trafficking and signalling. Biochem Soc Trans 2001; 29:472-75
69. McCampbell A, Fischbeck KH. Polyglutamine and CBP: Fatal attraction? Nat Med 2001;7:528-30
70. Zhang Y, Gao J, Chung KK, et al. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A 2000;97:13354-59
71. Rankin CA, Joazeiro CA, Floor E, Hunter T. E3 ubiquitin-protein ligase activity of Parkin is dependent on cooperative interaction of RING finger (TRIAD) elements. J Biomed Sci 2001;8:421-29
72. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-52
73. Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neurodegenerative disease. Science 2002;296:1991-95
74. Clague MJ. Membrane transport: A coat for ubiquitin. Curr Biol 2002;12:R529-31
75. Wunderlich W, Fialka I, Teis D, et al. A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment. J Cell Biol 2001;152: 765-76
76. Di Fiore PP, De Camilli P. Endocytosis and signaling. An inseparable partnership. Cell 2001;106:1-4
77. Sherman MY, Goldberg AL. Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases. Neuron 2001;29:15-32
78. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 2001;414:643-48
79. Sisodia SS. Biomedicine. A cargo receptor mystery apparently solved? Science 2002;295:805-7
80. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 2002;156: 1051-63
81. Naruse S, Thinakaran G, Luo JJ, et al. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 1998;21: 1213-21
82. Koliatsos VE, Clatterbuck RE, Nauta HJ, et al. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann Neurol 1991;30:831-40
83. Capsoni S, Ugolini G, Comparini A, et al. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci U S A 2000;97:6826-31
84. Bamji SX, Majdan M, Pozniak CD, et al. The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J Cell Biol 1998;140:911-23
85. Vesa J, Kruttgen A, Shooter EM. p75 Reduces TrkB Tyrosine Autophosphorylation in Response to BDNF and NT-4/5. [Record Supplied By Publisher]. J Biol Chem 2000;23
86. Francis NJ, Landis SC. Cellular and molecular determinants of sympathetic neuron development. Annu Rev Neurosci 1999;22: 541-66
87. Cooper JD, Salehi A, Delcroix JD, et al. Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci U S A 2001;98:10439-44
88. Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA. Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 1995;15:6213-21
89. Edwards RH, Selby MJ, Mobley WC, et al. Processing and secretion of nerve growth factor: Expression in mammalian cells with a vaccinia virus vector. Mol Cell Biol 1988;8:2456-64
90. Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science 2001;294:1945-48
91. Mowla SJ, Farhadi HF, Pareek S, et al. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem 2001;276:12660-66
92. Heymach JV, Jr, Kruttgen A, Suter U, Shooter EM. The regulated secretion and vectorial targeting of neurotrophins in neuroendocrine and epithelial cells. J Biol Chem 1996;271:25430-37
93. Williamson TL, Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 1999;2:50-56
94. Thoenen H, Sendtner M. Neurotrophins: From enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat Neurosci (Suppl) 2002;5:1046-50
95. Kordower JH, Emborg ME, Bloch J, et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 2000;290:767-73
96. Massa SM, Xie Y, Longo FM. Alzheimer's therapeutics: Neurotrophin small molecule mimetics. J Mol Neurosci 2002;19:107-11
97. Martinez-Serrano A, Bjorklund A. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J Neurosci 1996;16:4604-16